Laurion Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-11,900
Closed -$1.47M – 1103
2020
Q2
$1.47M Buy
+11,900
New +$1.4M 0.02% 351
2019
Q4
– Sell
-23,400
Closed -$1.79M – 1173
2019
Q3
$1.79M Buy
23,400
+1,709
+8% +$149K 0.01% 523
2019
Q2
$1.86M Buy
+21,691
New +$1.48M 0.02% 413
2018
Q4
– Sell
-88,359
Closed -$4.9M – 1353
2018
Q3
$4.9M Buy
+88,359
New +$4.55M 0.05% 358
2017
Q3
– Sell
-6,200
Closed -$257K – 1854
2017
Q2
$257K Buy
+6,200
New +$236K ﹤0.01% 1480

Other funds holding RGEN

Laurion Capital Management's RGEN Position: Q3 2020 in Review

Laurion Capital Management sold out of Repligen (RGEN) in Q3 2020, closing a stake of 11,900 shares — an estimated $1.47M sold.

Laurion Capital Management first reported a position in RGEN in Q2 2017 and held it in 5 quarters. The position peaked at $4.9M in Q3 2018. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Laurion Capital Management reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Laurion Capital Management sold 11,900 Repligen shares in Q3 2020, an estimated $1.47M.
  • Laurion Capital Management first reported a position in Repligen in Q2 2017 and held it in 5 quarters.
  • Laurion Capital Management's Repligen position peaked at $4.9M in Q3 2018.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.